Borgstrom, P; Bourdon, M A; Hillan, K J et al. (1998) Neutralizing anti-vascular endothelial growth factor antibody completely inhibits angiogenesis and growth of human prostate carcinoma micro tumors in vivo. Prostate 35:1-10
|
Deryugina, E I; Bourdon, M A; Reisfeld, R A et al. (1998) Remodeling of collagen matrix by human tumor cells requires activation and cell surface association of matrix metalloproteinase-2. Cancer Res 58:3743-50
|
Deryugina, E I; Bourdon, M A; Luo, G X et al. (1997) Matrix metalloproteinase-2 activation modulates glioma cell migration. J Cell Sci 110 ( Pt 19):2473-82
|
Deryugina, E I; Luo, G X; Reisfeld, R A et al. (1997) Tumor cell invasion through matrigel is regulated by activated matrix metalloproteinase-2. Anticancer Res 17:3201-10
|
Schwabe, M; Deryugina, E I; Bosco, M C et al. (1996) IL-6 signals inhibition of cell adhesion in melanoma A375-C6. Anticancer Res 16:3363-70
|
Deryugina, E I; Bourdon, M A (1996) Tenascin mediates human glioma cell migration and modulates cell migration on fibronectin. J Cell Sci 109 ( Pt 3):643-52
|
Deryugina, E I; Strongin, A; Yu, C et al. (1996) A novel monoclonal antibody, L1A3, is directed to the functional site of the alpha v integrin subunit. Hybridoma 15:279-88
|
Deryugina, E I; Ratnikov, B I; Bourdon, M A et al. (1995) Identification of a growth factor for primary murine stroma as macrophage colony-stimulating factor. Blood 86:2568-78
|
Torres Filho, I P; Hartley-Asp, B; Borgstrom, P (1995) Quantitative angiogenesis in a syngeneic tumor spheroid model. Microvasc Res 49:212-26
|
Sriramarao, P; Mendler, M; Bourdon, M A (1993) Endothelial cell attachment and spreading on human tenascin is mediated by alpha 2 beta 1 and alpha v beta 3 integrins. J Cell Sci 105 ( Pt 4):1001-12
|
Showing the most recent 10 out of 11 publications